Mexoryr SX Protects Against Solar‐Simulated UVR‐lnduced Photocarcinogenesis in Mice
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The aim of this study was to determine, for regulatory purposes, the potential of MexoryP SX, a broad UVA absorber that also absorbs to some extent in the UVB, to modify the UV radiation (UVR)‐induced murine skin tumor development and growth. Skh‐hrl mice were exposed to solar‐simulated UVR 5 days per week for 40 weeks. Two control groups were irradiated without topical application, three groups received a sunscreen preparation containing either the UVA absorber, MexoryP SX at 5 or 10% concentration, or a filter that absorbs principally in the UVB, 2‐ethylhexyl‐p‐methoxycinna‐mate (2‐EHMC) at 5% concentration, introduced as a comparator test article. Sunscreen application was performed before UVR exposure 3 days per week and after UVR exposure on the other 2 days (consistent with the design of a standard photocarcinogenesis safety test). Two different weekly UVR doses were administrated: the lower dose was given to one group of unprotected animals, whereas the higher dose was administrated to the other unprotected group and to the three sunscreen‐treated groups. The two UVR control groups demonstrated a UVR‐dependent response for cumulative tumor prevalence, tumor yield and median latent period. Neither concentration of Mexoryl SX increased the probability of tumor development; consistent with the principles for safety testing, this provides evidence in that it is safe for use in sunlight. Although this study was explicitly designed as a safety test, the results also provide some clues about the efficacy of MexoryP SX in decreasing the probability of tumor development. Topical administration of Mexoryl* SX, at both concentrations, resulted in a 6 week delay in the median latent period compared to high UVR controls, whereas 5% 2‐EHMC delayed the median latent periods only by 2 weeks. Tumor prevalence and yield show the same efficacy differences between the two sunscreen ingredients. Tumor protection factors were calculated from these results and found to be equal to 2.4 for the two preparations containing Mexoryl* SX and to 1.3 for the 5% 2‐EHMC preparation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photostability assessment of sunscreens. Benzylidene camphor and dibenzoylmethane derivatives
DEFLANDRE, A., & LANG, G. (1988) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.1988.tb00002.x · Cited by 124
Cited by
A Review of Sunscreen Safety and Efficacy
Gasparro, F. P., Mitchnick, M., & Nash, J. F. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb09677.x · Cited by 423
Kullavanijaya, P., & Lim, H. W. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.07.063 · Cited by 356
Human safety and efficacy of ultraviolet filters and sunscreen products
Nash, J. (2006) · Dermatologic Clinics · doi:10.1016/j.det.2005.09.006 · Cited by 126
An organotypic model of skin to study photodamage and photoprotection in vitro
Bernerd, F., & Asselineau, D. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.050 · Cited by 86
Quinolines derivatives as novel sunscreening agents
Polonini, H. C., Dias, R. M. P., Souza, I. O., Gonçalves, K. M., Gomes, T. B. B., Raposo, N. R. B., & da Silva, A. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.046 · Cited by 13
Metadata
- Authors
- Fourtanier, A.
- Venue
- Photochemistry and Photobiology
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 64
- Issue
- 4
- Pages
- 688-693
- ISSN
- 0031-8655 (ISSN-L)
- 1751-1097
- OpenAlex
- W2025292428
- Cited by
- 44
- References
- 1
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mexoryr SX Protects Against Solar‐Simulated UVR‐lnduced Photocarcinogenesis in Mice. https://app.cochat.ai/papers/10.1111/j.1751-1097.1996.tb03125.x
- The paper
- Fourtanier, A. (1996). Mexoryr SX Protects Against Solar‐Simulated UVR‐lnduced Photocarcinogenesis in Mice. Photochemistry and Photobiology. https://doi.org/10.1111/j.1751-1097.1996.tb03125.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.